When living with metastatic colorectal cancer (mCRC)...
The little things feel even bigger. So I fight even harder.
CYRAMZA is used with a chemotherapy combination called FOLFIRI (irinotecan, folinic acid, and fluorouracil) to treat metastatic colorectal cancer (mCRC) in patients whose cancer has progressed after being treated with other certain types of chemotherapy.
SELECT SAFETY INFORMATION
CYRAMZA may cause serious side effects, including:
Severe bleeding, including bleeding in the stomach or bowel, has happened with CYRAMZA. This can be life threatening. Tell your doctor right away if you have bleeding or symptoms of bleeding, including lightheadedness. If severe bleeding happens, you will have to stop receiving CYRAMZA.
Understanding your condition
Colorectal cancer is a cancer that starts in your colon or rectum, which are both parts of your digestive, or gastrointestinal (GI), system. Depending on where your cancer started, it may be referred to as either colon cancer or rectal cancer.
What is metastatic colorectal cancer?
When a cancer is referred to as metastatic cancer, that means it has spread from the place where it started (your colon or rectum) to other parts of the body. If the cancer has spread to farther parts of the body (for example, from the colon or rectum to the liver), then the cancer is considered to have metastasized.
What is staging?
Your doctor may talk to you about the stage of your disease, using numbers that indicate the level of severity. For example, stage 0 is less severe, whereas stage 4 colorectal cancer is more severe. Colorectal cancer treatments may vary by stage, so this can help guide your doctor on the options that make most sense for you.